» Articles » PMID: 1664344

Antipoliomyelitis Immunity Status Among a Population That Was Regularly Vaccinated 11-12 Years Before

Overview
Journal Eur J Epidemiol
Specialty Public Health
Date 1991 Nov 1
PMID 1664344
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A study of poliomyelitis neutralizing antibodies was carried out on 165 samples of blood serum drawn from subjects aged 14-15 years who had completed vaccination with OPV 11 or 12 years ago. Two different methods of incubation of the serum-virus mixtures (1 hour at 37 degrees C; 6 hours at 37 degrees C and then 18 hours at 4 degrees C, respectively) and two different cell lines (RC-37 and Hep-2) for the inoculation of these mixtures were employed. The results were also evaluated in relation to different initial dilutions of the sera (from 1:4 to 1:1). With the 1:4 initial serum dilution the highest frequencies of sero-negativity were observed utilizing the short incubation time and inoculation in Hep-2 (42% for polio 1, 10% for polio 2, 32% for polio 3). These frequencies diminish significantly utilizing the RC-37 cell line and the long incubation respectively. Under all the experimental conditions the results were better when the 1:2 initial serum dilutions were employed and even better when undiluted sera were used. Neutralizing antibodies against the 3 types of poliovirus were detected in the undiluted sera of all the subjects utilizing the long incubation and inoculation in either the RC-37 or the Hep-2 cell lines. In three subjects lacking detectable antibodies at the 1:4 dilution of the sera, the administration of a dose of IPV produced after 5-7 days a high response which remained almost unchanged 30 days later.

Citing Articles

Antipoliomyelitis neutralizing antibodies in maternal and neonatal serum.

Tanzi M, Colotto P, Vignali M, Affanni P, Bracchi U, Bellelli E Eur J Epidemiol. 1997; 13(5):559-65.

PMID: 9258569 DOI: 10.1023/a:1007345930234.


Persistence of immunity to poliomyelitis among a southern population that received four doses of OPV 5 to over 15 years before.

Triassi M, Ribera G, Barruffo L, Barbone S, Medda E, Grandolfo M Eur J Epidemiol. 1996; 12(1):5-8.

PMID: 8817170 DOI: 10.1007/BF00144420.

References
1.
Rooney M, Coyle P, Connolly J . Prevalence of antibody to poliovirus. Br Med J (Clin Res Ed). 1986; 293(6561):1571. PMC: 1342347. DOI: 10.1136/bmj.293.6561.1571. View

2.
Salk D . Eradication of poliomyelitis in the United States. III. Poliovaccines--practical considerations. Rev Infect Dis. 1980; 2(2):258-73. DOI: 10.1093/clinids/2.2.258. View

3.
SALK J . Present status of the problem of vaccination against poliomyelitis. Am J Public Health Nations Health. 1955; 45(3):285-97. PMC: 1623144. DOI: 10.2105/ajph.45.3.285. View

4.
Sanders D, Cramblett H . Antibody titers to polioviruses in patients ten years after immunization with sabin vaccine. J Pediatr. 1974; 84(3):406-8. DOI: 10.1016/s0022-3476(74)80726-2. View

5.
PROFETA M, Pazardjiklian I . [Biological and biochemical characteristics of poliovirus strains isolated after the introduction of oral antipoliomyelitis vaccine]. Ann Sclavo. 1982; 24(5):545-59. View